| Comparison of two highly-effective mRNA vaccines for COVID-19 during periods of Alpha and Delta variant prevalence A Puranik, PJ Lenehan, E Silvert, MJM Niesen, J Corchado-Garcia, ... MedRxiv, 2021 | 282 | 2021 |
| FDA-authorized mRNA COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system C Pawlowski, P Lenehan, A Puranik, V Agarwal, AJ Venkatakrishnan, ... Med 2 (8), 979-992. e8, 2021 | 203 | 2021 |
| Casirivimab–Imdevimab treatment is associated with reduced rates of hospitalization among high-risk patients with mild to moderate coronavirus disease-19 RR Razonable, C Pawlowski, JC O'Horo, LL Arndt, R Arndt, DM Bierle, ... EClinicalMedicine 40, 2021 | 130 | 2021 |
| Analysis of the effectiveness of the Ad26. COV2. S adenoviral vector vaccine for preventing COVID-19 J Corchado-Garcia, D Zemmour, T Hughes, H Bandi, T Cristea-Platon, ... JAMA network open 4 (11), e2132540-e2132540, 2021 | 98 | 2021 |
| Critical role for arginase 2 in obesity-associated pancreatic cancer T Zaytouni, PY Tsai, DS Hitchcock, CD DuBois, E Freinkman, L Lin, ... Nature communications 8 (1), 242, 2017 | 90 | 2017 |
| Inhibition of CDK4/6 promotes CD8 T-cell memory formation M Heckler, LR Ali, E Clancy-Thompson, L Qiang, KS Ventre, P Lenehan, ... Cancer discovery 11 (10), 2564-2581, 2021 | 71 | 2021 |
| Omicron variant of SARS-CoV-2 harbors a unique insertion mutation of putative viral or human genomic origin AJ Venkatakrishnan, P Anand, P Lenehan, R Suratekar, B Raghunathan, ... OSF, 2021 | 68 | 2021 |
| Real-time analysis of a mass vaccination effort confirms the safety of FDA-authorized mRNA COVID-19 vaccines R McMurry, P Lenehan, S Awasthi, E Silvert, A Puranik, C Pawlowski, ... Med 2 (8), 965-978. e5, 2021 | 58 | 2021 |
| Cerebral venous sinus thrombosis is not significantly linked to COVID-19 vaccines or non-COVID vaccines in a large multi-state health system C Pawlowski, J Rincón-Hekking, S Awasthi, V Pandey, P Lenehan, ... Journal of Stroke and Cerebrovascular Diseases 30 (10), 105923, 2021 | 39 | 2021 |
| Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19 R Ganesh, CF Pawlowski, JC O’Horo, LL Arndt, RF Arndt, SJ Bell, ... The Journal of clinical investigation 131 (19), 2021 | 37 | 2021 |
| cIAP1/2 antagonism eliminates MHC class I–negative tumors through T cell–dependent reprogramming of mononuclear phagocytes K Roehle, L Qiang, KS Ventre, D Heid, LR Ali, P Lenehan, M Heckler, ... Science translational medicine 13 (594), eabf5058, 2021 | 32 | 2021 |
| COVID-19 vaccines dampen genomic diversity of SARS-CoV-2: Unvaccinated patients exhibit more antigenic mutational variance MJM Niesen, P Anand, E Silvert, R Suratekar, C Pawlowski, P Ghosh, ... MedRxiv, 2021.07. 01.21259833, 2021 | 31 | 2021 |
| SARS-CoV-2 and influenza coinfection throughout the COVID-19 pandemic: an assessment of coinfection rates, cohort characteristics, and clinical outcomes C Pawlowski, E Silvert, JC O'Horo, PJ Lenehan, D Challener, E Gnass, ... PNAS nexus 1 (3), pgac071, 2022 | 29 | 2022 |
| Surveillance of safety of 3 doses of COVID-19 mRNA vaccination using electronic health records MJM Niesen, C Pawlowski, JC O’Horo, DW Challener, E Silvert, ... JAMA network open 5 (4), e227038-e227038, 2022 | 25 | 2022 |
| Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection A Puranik, PJ Lenehan, E Silvert, MJM Niesen, J Corchado-Garcia, ... Med 3 (1), 28-41. e8, 2022 | 23 | 2022 |
| Durability analysis of the highly effective BNT162b2 vaccine against COVID-19 A Puranik, PJ Lenehan, JC O'Horo, C Pawlowski, MJM Niesen, A Virk, ... PNAS nexus 1 (3), pgac082, 2022 | 20 | 2022 |
| FDA-authorized COVID-19 vaccines are effective per real-world evidence synthesized across a multi-state health system. medRxiv. 2021 C Pawlowski, P Lenehan, A Puranik, V Agarwal, AJ Venkatakrishnan, ... DOI 10 (2021.02), 15.21251623, 0 | 16 | |
| Type 2 immunity is maintained during cancer-associated adipose tissue wasting PJ Lenehan, A Cirella, AM Uchida, SJ Crowley, T Sharova, G Boland, ... Immunotherapy Advances 1 (1), ltab011, 2021 | 15 | 2021 |
| On the origins of omicron’s unique spike gene insertion AJ Venkatakrishnan, P Anand, PJ Lenehan, R Suratekar, B Raghunathan, ... Vaccines 10 (9), 1509, 2022 | 13 | 2022 |
| An evaluation strategy for potential QTc prolongation with chronic azithromycin therapy in cystic fibrosis PJ Lenehan, CM Schramm, MS Collins Journal of Cystic Fibrosis 15 (2), 192-195, 2016 | 13 | 2016 |
